Inovio Pharmaceuticals Newsroom

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaDec 14 05:06

Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet

BenzingaDec 14 03:10

Top Midday Decliners

MT NewswiresDec 14 02:41

Inovio Pharmaceuticals Shares Touch 52-Week Low After $30M Offering

WSJDec 14 02:11

Crude Oil Gains Over 1%; RH Shares Jump On Strong Forecast

BenzingaDec 14 01:22

US Stocks Mixed; Broadcom Shares Surge On Upbeat Earnings

BenzingaDec 13 23:39

Why Inovio Pharmaceuticals (INO) Stock Is Down 40%

BenzingaDec 13 23:38

Wall Street Set to Open Higher Friday as Investors Shake Off Bad Week

MT NewswiresDec 13 22:11

Investors Look to End Week on Strong Note as US Futures Rise in Friday's Premarket

MT NewswiresDec 13 21:05

Inovio Pharmaceuticals Priced An Underwritten Public Offering Of 10M Shares And Accompanying Warrants To Purchase 10M Shares At An Exercise Price Of $3.76/Share, At A Combined Public Offering Price Of $3/Share And Accompanying Warrant, With Gross...

BenzingaDec 13 20:03

Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

BenzingaDec 13 18:30

RH, Broadcom And 3 Stocks To Watch Heading Into Friday

BenzingaDec 13 14:56

Inovio Down 20% After Hours on Planned Stock and Warrant Sale

WSJDec 13 07:49

Express News | Inovio Announces Proposed Public Offering

BreakingsDec 13 05:01

INOVIO Announces Proposed Public Offering

PR NewswireDec 13 05:01

The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA

Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.

wallstreetcnDec 9 11:20

Inovio Pharmaceuticals' INO-3107 Shows Promising Clinical Trial Results, Earns 'Buy' Rating From Analyst

TipRanksDec 5 23:28 · Ratings

Analysts Are Bullish on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Replimune Group (REPL)

TipRanksDec 5 23:21 · Ratings

Express News | Inovio Pharmaceuticals Inc - No Serious Adverse Events Identified in Retrospective Trial

BreakingsDec 3 21:00

Express News | Inovio Pharmaceuticals Inc - New Data to Inform Re-Dosing Strategy for Rrp Treatment

BreakingsDec 3 21:00